American Journal of Perinatology 2011-06-01

Oxytocin antagonists for the management of preterm birth: a review.

Ihab M Usta, Ali Khalil, Anwar H Nassar

Index: Am. J. Perinatol. 28(6) , 449-60, (2011)

Full Text: HTML

Abstract

Preterm birth, the leading cause of neonatal morbidity and mortality, is estimated at incidence of 12.7% of all births, which has not decreased over the last four decades despite intensive antenatal care programs aimed at high-risk groups, the widespread use of tocolytics, and a series of other preventive and therapeutic interventions. Oxytocin antagonists, namely atosiban, represent an appealing choice that seems to be effective with apparently fewer side effects than the traditional tocolytics. This article reviews the available literature on the pharmacokinetics, mode of administration, and clinical utility of oxytocin antagonists for acute and maintenance tocolysis with special emphasis on its safety profile.© Thieme Medical Publishers.

Related Compounds

  • SR 49059

Related Articles:

The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.

2015-06-01

[Neuropeptides 51 , 63-73, (2015)]

Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

2015-05-01

[Diabetologia 58(5) , 1081-90, (2015)]

Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model.

2012-11-01

[Am. J. Respir. Cell. Mol. Biol. 47(5) , 583-8, (2012)]

Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor.

2006-05-26

[J. Biol. Chem. 281(21) , 14604-14, (2006)]

Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

2011-03-01

[Neurochem. Int. 58(4) , 542-8, (2011)]

More Articles...